Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LLY · against 1,370 other Healthcare companies
Ranked #1,191 of 1,371 · scores higher than 13% of peers · safety percentile 13
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 10–19, including LLY · Click a bar to see the companies
Mainly because of its debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | LLY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,281 reported | 1.62× | 0.24× | 9% | 33% | |
| BetaLower is better · 1,333 reported | 0.50 | 0.53 | 51% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.35× | 2.59× | 21% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 510M USD | 100 | ||
| 1 | 4.6B USD | 100 | 54 | |
| 1 | 5.3B USD | 100 | 45 | |
| 4 | 252M USD | 100 | 52 | |
| 5 | 1.9B USD | 100 | 44 | |
| 1,187 | 14.5B USD | 13 | 37 | |
| 1,188 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 6.1B USD |
| 13 |
| 32 |
| 1,189 | 9.5B SAR (≈$2.6B) | 13 | 54 |
| 1,190 | 176.5B JPY (≈$1.2B) | 13 | 44 |
| 1,191 | 1.06T USD | 13 | 63 |
| 1,192 | 5.7B USD | 13 |
| 1,193 | 14.3B EUR (≈$15.7B) | 13 | 47 |
| 1,194 | 390.9B JPY (≈$2.7B) | 13 | 51 |
| 1,195 | 4.3B CNY (≈$603M) | 13 | 29 |